Reaction
Gastritis Haemorrhagic reporting signals
As of the last recalculation, Gastritis Haemorrhagic appears in 1,485 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is RIVAROXABAN (PRR 27.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rivaroxaban | 319 | 27.1 | 27.1 |
| Sucralfate | 23 | 13.7 | 13.7 |
| Ifosfamide | 19 | 12.5 | 12.6 |
| Dabigatran Etexilate | 63 | 11.8 | 11.8 |
| Dabigatran Etexilate Mesylate | 55 | 11.0 | 11.0 |
| Dronedarone | 6 | 8.3 | 8.3 |
| Belimumab | 17 | 7.6 | 7.6 |
| Prasugrel Hydrochloride | 5 | 6.9 | 6.9 |
| Deferasirox | 11 | 5.9 | 5.9 |
| Ticagrelor | 13 | 5.8 | 5.8 |
| Azacitidine | 12 | 5.7 | 5.7 |
| Azacitidine For | 7 | 5.4 | 5.4 |
| Ipilimumab | 14 | 4.6 | 4.6 |
| Nivolumab | 29 | 4.3 | 4.3 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 3 | 3.8 | 3.8 |
| Cinacalcet Hydrochloride | 5 | 1.5 | 1.5 |